Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Rosenstein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|March 19, 2016
Lupus miliaris disseminatus facieiRachel Cymerman, Rachel Rosenstein, Marianna Shvartsbeyn, et al.
Dermatology Online Journal|March 23, 2017
Idiopathic scleredemaElise Ng, Rachel Rosenstein, Vitaly Terushkin, et al.
Dermatology Online Journal|March 23, 2017
Sarcoidosis with prominent necrosis on histopathologyRachel Rosenstein, Charisse Orme, Randie H Kim, et al.
Dermatology Online Journal|March 19, 2016
Primary diffuse macular amyloidosisMelissa Kanchanapoomi, Rachel Rosenstein, Marianna Shvartsbeyn, et al.
Dermatology Online Journal|March 23, 2017
Dermatomyositis, clinically presenting with cutaneous ulcers, with histopathologic evidence of perforating collagenosisRachel Rosenstein, Kathryn Martires, Mitalee Christman, et al.
Cancer Letters|December 20, 2014
A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivoThomas C Chen, Hee-Yeon Cho, Weijun Wang, et al.
Molecular Biology of the Cell|October 26, 2007
Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeastMatthew J Brauer, Curtis Huttenhower, Edoardo M Airoldi, et al.
Journal of Neurosurgery|April 15, 2017
Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor modelWeijun Wang, Hee-Yeon Cho, Rachel Rosenstein-Sisson, et al.
Cancer Letters|December 20, 2015
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsNiyati Jhaveri, Fabienne Agasse, Don Armstrong, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|March 19, 2016
Lupus miliaris disseminatus facieiRachel Cymerman, Rachel Rosenstein, Marianna Shvartsbeyn, et al.
Dermatology Online Journal|March 23, 2017
Idiopathic scleredemaElise Ng, Rachel Rosenstein, Vitaly Terushkin, et al.
Dermatology Online Journal|March 23, 2017
Sarcoidosis with prominent necrosis on histopathologyRachel Rosenstein, Charisse Orme, Randie H Kim, et al.
Dermatology Online Journal|March 19, 2016
Primary diffuse macular amyloidosisMelissa Kanchanapoomi, Rachel Rosenstein, Marianna Shvartsbeyn, et al.
Dermatology Online Journal|March 23, 2017
Dermatomyositis, clinically presenting with cutaneous ulcers, with histopathologic evidence of perforating collagenosisRachel Rosenstein, Kathryn Martires, Mitalee Christman, et al.
Cancer Letters|December 20, 2014
A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivoThomas C Chen, Hee-Yeon Cho, Weijun Wang, et al.
Molecular Biology of the Cell|October 26, 2007
Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeastMatthew J Brauer, Curtis Huttenhower, Edoardo M Airoldi, et al.
Journal of Neurosurgery|April 15, 2017
Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor modelWeijun Wang, Hee-Yeon Cho, Rachel Rosenstein-Sisson, et al.
Cancer Letters|December 20, 2015
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsNiyati Jhaveri, Fabienne Agasse, Don Armstrong, et al.
Pageof 1